BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29523532)

  • 1. Treatment patterns for patients hospitalized with chronic obstructive pulmonary disease.
    Amin AN; Bollu V; Stensland MD; Netzer L; Ganapathy V
    Am J Health Syst Pharm; 2018 Mar; 75(6):359-366. PubMed ID: 29523532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-acting bronchodilators with or without inhaled corticosteroids and 30-day readmission in patients hospitalized for COPD.
    Bishwakarma R; Zhang W; Kuo YF; Sharma G
    Int J Chron Obstruct Pulmon Dis; 2017; 12():477-486. PubMed ID: 28203071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction in Hospital Readmission Rates Among Medicare Beneficiaries With Chronic Obstructive Pulmonary Disease: A Real-world Outcomes Study of Nebulized Bronchodilators.
    Keshishian A; Xie L; Dembek C; Yuce H
    Clin Ther; 2019 Nov; 41(11):2283-2296. PubMed ID: 31630815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use and outcomes associated with long-acting bronchodilators among patients hospitalized for chronic obstructive pulmonary disease.
    Lindenauer PK; Shieh MS; Pekow PS; Stefan MS
    Ann Am Thorac Soc; 2014 Oct; 11(8):1186-94. PubMed ID: 25167078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
    Ohar JA; Donohue JF
    Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends and Factors Associated with Nebulized Therapy Prescription in Older Adults with Chronic Obstructive Pulmonary Disease from 2008 to 2015.
    Singh M; Duarte AG; Hsu ES; Kuo YF; Sharma G
    J Aerosol Med Pulm Drug Deliv; 2020 Jun; 33(3):161-169. PubMed ID: 32017642
    [No Abstract]   [Full Text] [Related]  

  • 7. Switching to nebulised short acting bronchodilators does not increase the risk of arrhythmia in patients hospitalized with a COPD exacerbation.
    Santus P; Franceschi E; Pini S; Frassanito F; Amati F; Danzo F; Gatti M; Radovanovic D
    Pharmacol Res; 2021 Nov; 173():105915. PubMed ID: 34571145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additive efficacy of short-acting bronchodilators on dynamic hyperinflation and exercise tolerance in stable COPD patients treated with long-acting bronchodilators.
    Kitaguchi Y; Fujimoto K; Komatsu Y; Hanaoka M; Honda T; Kubo K
    Respir Med; 2013 Mar; 107(3):394-400. PubMed ID: 23245993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK.
    Edwards SC; Fairbrother SE; Scowcroft A; Chiu G; Ternouth A; Lipworth BJ
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2851-2858. PubMed ID: 27920512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospital readmissions following initiation of nebulized arformoterol tartrate or nebulized short-acting beta-agonists among inpatients treated for COPD.
    Bollu V; Ernst FR; Karafilidis J; Rajagopalan K; Robinson SB; Braman SS
    Int J Chron Obstruct Pulmon Dis; 2013; 8():631-9. PubMed ID: 24353413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication management patterns among Medicare beneficiaries with chronic obstructive pulmonary disease who initiate nebulized arformoterol treatment.
    Celli BR; Navaie M; Xu Z; Cho-Reyes S; Dembek C; Gilmer TP
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1019-1031. PubMed ID: 31190787
    [No Abstract]   [Full Text] [Related]  

  • 12. Chronic obstructive pulmonary disease: prevalence, characteristics, and pharmacologic treatment in nursing home residents with cognitive impairment.
    Zarowitz BJ; O'Shea T
    J Manag Care Pharm; 2012 Oct; 18(8):598-606. PubMed ID: 23127147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Effectiveness of Long-Acting Beta
    Samp JC; Joo MJ; Schumock GT; Calip GS; Pickard AS; Lee TA
    Pharmacotherapy; 2017 Apr; 37(4):447-455. PubMed ID: 28226405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
    Blais L; Forget A; Ramachandran S
    Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study.
    Casas A; Montes de Oca M; Menezes AM; Wehrmeister FC; Lopez Varela MV; Mendoza L; Ramírez L; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1545-1556. PubMed ID: 29785104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exacerbation recovery patterns in newly diagnosed or maintenance treatment-naïve patients with COPD: secondary analyses of TICARI 1 trial data.
    Mannino DM; Clerisme-Beaty EM; Franceschina J; Ting N; Leidy NK
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1515-1525. PubMed ID: 29785101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reasons for triple therapy in stable COPD patients in Japanese clinical practice.
    Miyazaki M; Nakamura H; Takahashi S; Chubachi S; Sasaki M; Haraguchi M; Terai H; Ishii M; Fukunaga K; Tasaka S; Soejima K; Asano K; Betsuyaku T;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1053-9. PubMed ID: 26082629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of prompt versus delayed initiation of triple therapy post COPD exacerbation in a US-managed care setting.
    Bogart M; Glassberg MB; Reinsch T; Stanford RH
    Respir Med; 2018 Dec; 145():138-144. PubMed ID: 30509702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of inhaled devices during a hospital exacerbation of COPD: a summary of an interdisciplinary audit held at ICS Maugeri Pavia, Italy (March-June 2019).
    Vitacca M; Lastoria C; Delmastro M; Fiorenza D; De Cata P; Fusar Poli B; Gilè S; Prometti P; Paneroni M; Bianchi C; Mandora E; Porri R; Fracchia C
    Monaldi Arch Chest Dis; 2020 Feb; 90(1):. PubMed ID: 32072800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex Differences in Veterans Admitted to the Hospital for Chronic Obstructive Pulmonary Disease Exacerbation.
    Bade BC; DeRycke EC; Ramsey C; Skanderson M; Crothers K; Haskell S; Bean-Mayberry B; Brandt C; Bastian LA; Akgün KM
    Ann Am Thorac Soc; 2019 Jun; 16(6):707-714. PubMed ID: 30822098
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.